News & Updates
Filter by Specialty:
Oral tebipenem pivoxil hydrobromide works against complicated UTI, acute pyelonephritis
Oral tebipenem pivoxil hydrobromide appears to be as good as intravenous ertapenem in the treatment of patients with complicated urinary tract infection (UTI) and acute pyelonephritis, with the two having a similar safety profile, according to data from a phase III study.
Oral tebipenem pivoxil hydrobromide works against complicated UTI, acute pyelonephritis
16 May 2022Short-term ADT leads to worse survival in prostate cancer patients on IMRT
Short-term concurrent androgen deprivation therapy (ADT) results in markedly worse overall survival (OS) among intermediate-risk (IR) prostate cancer patients on dose-escalated intensity modulated radiation therapy (IMRT) with daily image-guided RT, reveals a study.
Short-term ADT leads to worse survival in prostate cancer patients on IMRT
12 May 2022Overweight, obesity up risk of urinary incontinence
Chronic, increased body mass index (BMI) may lead to an increased risk of urinary incontinence (UI) later in life, according to a study of postmenopausal women. In addition, symptom severity may get worse with the duration of increased BMI status.
Overweight, obesity up risk of urinary incontinence
11 May 2022Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
The eutectic-like mixture of prilocaine/lidocaine spray appears to work well in the treatment of men with various types of premature ejaculation, as reflected by a high treatment adherence, according to data from a real-world study.